Hexagon Nutrition IPO Review 2026: Dates, Price, Financials & Should You Apply?

The Hexagon Nutrition IPO is opening for subscription in June 2026 and has attracted attention from investors looking for opportunities in India’s growing nutrition and wellness industry. Hexagon Nutrition is a research-driven nutrition company with a strong presence in micronutrient premixes, clinical nutrition products, and wellness solutions. The company exports its products to more than 75 countries and serves leading FMCG companies, healthcare organizations, and government nutrition programs.

In this article, we cover the IPO dates, price band, lot size, company details, financial performance, competitors, and whether investors should apply for the IPO. Investors who are new to IPO investing can also learn the basics of stock market investing through our Technical Analysis Course at ISFM Technical Analysis Course.

Hexagon Nutrition IPO Details

The IPO aims to raise approximately ₹138.87 crore through an Offer for Sale (OFS), meaning the proceeds will go to existing shareholders rather than the company.

About Hexagon Nutrition

Founded in 1993, Hexagon Nutrition Limited is a nutrition-focused company engaged in the development, manufacturing, and marketing of a wide range of nutrition and wellness products.

The company operates across multiple categories, including:

• Micronutrient Premixes
• Clinical Nutrition Products
• Wellness Supplements
• Therapeutic Nutrition Solutions
• Ready-to-Use Foods (RUF)
• Micronutrient Powders (MNP)

Hexagon Nutrition serves both domestic and international markets and exports products to over 75 countries. The company has manufacturing facilities in Maharashtra, Tamil Nadu, and Uzbekistan.

Key Management

The company is led by experienced professionals from the nutrition and healthcare industry.

Managing Director & CEO

• Mr. Vikram Arun Kelkar

The management team has played an important role in expanding Hexagon Nutrition’s presence in India and global markets.

Major Products and Business Segments

Hexagon Nutrition offers a diversified portfolio of nutrition products:

1. Micronutrient Premixes

Customized vitamin and mineral blends supplied to food and beverage manufacturers.

2. Clinical Nutrition

Products designed for hospitals, healthcare institutions, and patient recovery.

3. Wellness Nutrition

Health supplements aimed at improving immunity, fitness, and overall well-being.

4. Therapeutic Nutrition

Specialized nutritional products used in public health and nutrition programs.

The company is considered one of India’s leading premix manufacturers and supplies several multinational FMCG companies.

Financial Performance

Hexagon Nutrition has shown steady growth due to rising demand for nutritional products and health supplements.

Key Strengths

• Established business with over three decades of operating history.
• Export presence in 75+ countries.
• Strong customer base including FMCG companies and healthcare organizations.
• Growing demand for nutrition and wellness products globally.
• Diversified product portfolio reducing dependence on a single segment.

At the upper price band of ₹45, the company is valued at approximately 15.35 times earnings (P/E Ratio), which appears reasonable compared to many consumer healthcare and wellness companies.

While analyzing IPOs, investors should not focus only on revenue growth and profits. Understanding valuation metrics, earnings growth, and industry trends is equally important. Those interested in learning company analysis can explore our Fundamental Analysis Course at ISFM Fundamental Analysis Course.

Competitors

Hexagon Nutrition competes with several companies in the nutrition, healthcare, and wellness sectors, including:

• Abbott India
• Nestlé India (Nutrition Division)
• Danone India
• GlaxoSmithKline Consumer Healthcare
• Herbalife Nutrition
• Amway Nutrition
• Torrent Pharmaceuticals (Nutraceutical Segment)

Although Hexagon operates in a niche segment, competition remains intense due to the presence of global and domestic nutrition brands.

Risks to Consider

Before applying, investors should consider the following risks:

• IPO is entirely an Offer for Sale (OFS), so the company will not receive fresh capital from the issue.
• Dependence on demand from healthcare and FMCG clients.
• Increasing competition in the nutrition and wellness sector.
• Export business can be affected by global economic conditions.

Conclusion

Hexagon Nutrition operates in a promising industry supported by increasing health awareness, growing demand for nutritional products, and expansion in global wellness markets. The company has a diversified product portfolio, international presence, and established customer relationships.

However, the IPO is entirely an Offer for Sale, and current GMP trends do not indicate strong listing gains. Investors should focus more on the company’s long-term growth potential rather than short-term listing expectations.

Successful IPO investing requires a combination of market knowledge, risk management, and proper stock selection. Investors looking to build professional trading and investing skills can consider the Chartered Stock Trading Expert (CSTX) Program offered by ISFM – International School of Financial Market.

Recommendation: Should You Apply?

For Listing Gain Investors

• Avoid / Neutral: Current GMP indicates limited listing gain potential.

For Long-Term Investors

• Apply with Moderate Expectations
• The nutrition and wellness sector offers long-term growth opportunities, and the valuation appears reasonable. Investors with a 3–5 year investment horizon may consider applying.

Overall Rating

Subscribe for Long Term | Neutral for Listing Gains

The IPO looks fairly priced and belongs to a growing sector, making it suitable for investors seeking long-term exposure to the nutrition and wellness industry.